Literature DB >> 11472818

In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels.

Y Y Wang1, C T Hong, W T Chiu, J Y Fang.   

Abstract

The purpose of this study was designed to investigate the in vitro and in vivo skin absorption of capsaicin and nonivamide from hydrogels. Various commercialized creams of capsaicin were also compared with hydrogels. Both skin stripping technique and Mexameter were applied to evaluate the level of capsaicin and nonivamide retained in stratum corneum (SC) and skin erythema in vivo. The partition of drug between skin and the hydrogel matrix was considered to play an important role in the permeation process. The in vitro permeation of capsaicin from hydrogels depends on the physicochemical nature and the concentration of the polymer used. The incorporation of nonionic Pluronic F-127 polymer into hydrogels resulted in a retarded release of capsaicin. On the other hand, the in vitro capsaicin permeation showed higher levels in cationic chitosan and anionic carboxymethyl cellulose (CMC) hydrogels than cream bases. The permeation of nonivamide was retarded at the late stage of in vitro application. The inter-subject variation was more significant in the in vivo study than in vitro skin permeation experiments. The cream induced in vivo skin erythema depending on the drug concentration, however, the dose-dependence was not observed in hydrogels. Nonivamide-treated skin showed stronger erythema than capsaicin-treated skin. The present study indicates that there is a moderate correlation between in vitro skin permeation and in vivo erythema responses of topically applied capsaicin and nonivamide. The correlation between drug amount in SC and skin erythema test in vivo was also observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472818     DOI: 10.1016/s0378-5173(01)00755-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  17 in total

1.  Skin targeting of resveratrol utilizing solid lipid nanoparticle-engrossed gel for chemically induced irritant contact dermatitis.

Authors:  S N Shrotriya; N S Ranpise; B V Vidhate
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

2.  Capsaicin inhibits catecholamine secretion and synthesis by blocking Na+ and Ca2+ influx through a vanilloid receptor-independent pathway in bovine adrenal medullary cells.

Authors:  Kojiro Takahashi; Yumiko Toyohira; Susumu Ueno; Masato Tsutsui; Nobuyuki Yanagihara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-10-07       Impact factor: 3.000

3.  Enhanced topical delivery of terbinafine hydrochloride with chitosan hydrogels.

Authors:  Ipek Ozcan; Ozlem Abaci; Alev Haliki Uztan; Buket Aksu; Hayal Boyacioğlu; Tamer Güneri; Ozgen Ozer
Journal:  AAPS PharmSciTech       Date:  2009-08-07       Impact factor: 3.246

4.  Manipulation of corticosteroid release from a transiently supersaturated topical metered dose aerosol using a residual miscible co-solvent.

Authors:  Monica L Reid; Marc B Brown; Stuart A Jones
Journal:  Pharm Res       Date:  2008-07-31       Impact factor: 4.200

5.  A drug-in-adhesive matrix based on thermoplastic elastomer: evaluation of percutaneous absorption, adhesion, and skin irritation.

Authors:  ChengXiao Wang; Ran Liu; XiuZhen Tang; Wei Han
Journal:  AAPS PharmSciTech       Date:  2012-09-08       Impact factor: 3.246

6.  Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo.

Authors:  Pinaki R Desai; Srujan Marepally; Apurva R Patel; Chandrashekhar Voshavar; Arabinda Chaudhuri; Mandip Singh
Journal:  J Control Release       Date:  2013-05-03       Impact factor: 9.776

Review 7.  Bioavailability of capsaicin and its implications for drug delivery.

Authors:  William D Rollyson; Cody A Stover; Kathleen C Brown; Haley E Perry; Cathryn D Stevenson; Christopher A McNees; John G Ball; Monica A Valentovic; Piyali Dasgupta
Journal:  J Control Release       Date:  2014-10-12       Impact factor: 9.776

8.  Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II.

Authors:  R Jayachandra Babu; Loice Kikwai; Lasha T Jaiani; Narayanasamy Kanikkannan; Cheryl A Armstrong; John C Ansel; Mandip Singh
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

9.  Development and Characterization of PLGA Nanoparticle-Laden Hydrogels for Sustained Ocular Delivery of Norfloxacin in the Treatment of Pseudomonas Keratitis: An Experimental Study.

Authors:  Rana M Gebreel; Noha A Edris; Hala M Elmofty; Mina I Tadros; Mohamed A El-Nabarawi; Doaa H Hassan
Journal:  Drug Des Devel Ther       Date:  2021-02-05       Impact factor: 4.162

10.  Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery.

Authors:  Jyotsana R Madan; Priyanka A Khude; Kamal Dua
Journal:  Int J Pharm Investig       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.